Document is current
Any future updates will be listed below
-
Authors
He, Juan
Zeng, Zhen
Wang, Yuelong
Deng, Jiaojiao
Tang, Xin
Liu, Fujun
Huang, Jianhan
Chen, Hongxu
Liang, Ruichao
Zan, Xin
Liu, Zhiyong
Tong, Aiping
Guo, Gang
Xu, Jianguo
Zhu, Xiaofeng
Zhou, Liangxue
Peng, Yong http://orcid.org/0000-0002-1181-3467
-
Funding
Funding for this research was provided by:
West China Hospital, Sichuan University (ZYGD20008, ZYJC18030, ZYJC18007)
National Natural Science Foundation of China (81772693, 82002648)
National Major Scientific and Technological Special Project for Significant New Drug Development (2019ZX09301-147)
Department of Science and Technology of Sichuan Province (2019YFS0392, 2019YFS0326)
Postdoctoral Research Foundation of China (2018M640922)
- License Information
-
More Information
Article History
Received: 21 October 2021
Accepted: 22 November 2021
First Online: 18 December 2021
Declarations
:
: The study was approved by the Biomedical Ethics Committee of West China Hospital of Sichuan University. All patients provided written informed consent for genomic analysis of their cancer as well as participation in the study.
: The authors approved the publication of this manuscript.
: The authors declare that they have no competing interests.
